Sky Labs Accelerates Global Push After KOSDAQ Listing on AI Medical Data Production Platform
TECHWORLD ·
✦ AI Summary
Sky Labs is set to list on the KOSDAQ market on the 4th.
After the listing, the company plans to accelerate its expansion into global markets and aims to strengthen its market position and evolve into a global medical data production platform.
Sky Labs developed the ring-type Cuffless blood pressure monitor CART BP pro, which has been adopted by more than 2,000 hospitals and clinics in South Korea, and overseas sales accounted for 52% in the first half of this year.
Sky Labs is set to list on the KOSDAQ market on the 4th. After the listing, the company plans to accelerate its expansion into global markets, with the goal of strengthening its market position and ultimately evolving into a global medical data production platform.
Sky Labs is the company that first developed Cuffless ring-type blood pressure monitors. Its flagship product, CART BP pro, is designed to measure blood pressure in real time while minimizing disruption to daily life and sleep. CART BP pro has been adopted by more than 2,000 hospitals and clinics nationwide, including major hospitals in South Korea.
According to the company, total prescriptions for 24-hour ambulatory blood pressure monitoring (E6547) in South Korea rose 52.7% in the year after CART BP pro was launched, compared with before the launch. The company said CART BP pro accounted for a 52.4% share of that market. It added that CART BP pro has created new demand across the overall testing market rather than simply replacing the existing market, and that this new demand creation supports its growth potential.
Following the signing of an IEM supply agreement, the company entered hospital and clinic markets in major European countries such as the U.K. and Germany. As a result, overseas sales accounted for 52% of revenue in the first half of this year.
Based on its expansion into major European markets, the company is expanding in Japan and preparing to enter the U.S. market. With this listing, it plans to push for further global expansion of its Cuffless blood pressure monitoring business.
In addition, the company plans to expand its business scope from its existing CART blood pressure monitor-centered structure into a multi-vital and medical data production platform. It plans to diversify its products into the multi-biosignal area and use CART NET, its medical data production platform. It also aims to become an AI medical data production platform based on AI algorithms, with direct production focused on biologic data with high clinical reliability. Based on this, it plans to expand into high value-added data areas such as pharmaceutical clinical trials and medical AI.
Sky Labs CEO Lee Byunghwan said the company plans to speed up the expansion of its overseas business after the listing, adding that it will focus on becoming a global medical data production platform company through the use of accumulated medical data.
Source: TECHWORLD · Kim Hye-jin
Original: https://www.epnc.co.kr/news/articleView.html?idxno=406548
References
This article was produced with the help of an automated content generation algorithm.
Source: TECHWORLD
View originalThis article was summarized and organized by BizCrush based on the original article from TECHWORLD. For exact quotations and full details, please refer to the original article.